Inferact
PrivateLast Round
Seed
Jan 23, 2026
Est. Valuation
$800M
Total Funding Raised
$150M
Company Overview
Inferact is an AI infrastructure company that develops and commercializes vLLM, an open-source large language model (LLM) inference engine designed to make AI inference faster and cheaper.
Sector
AI, Data & Cloud Infrastructure
Verticals
ML Platforms, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inferact Comps
Public and private peers based on sector, stage, and business model.
Inferact Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 23, 2026 |
Inferact Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| Laude Ventures | Seed |
| ZhenFund | Seed |
| Sequoia Capital | Seed |
| UC Berkeley Chancellor's Fund, LLC | Seed |
| GC&H Investments | Seed |
| Striker Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
AI startup founded by vLLM creators has officially launched.
- Jan 23, 2026
$150M raised at $800M post-money valuation.
Inferact Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inferact's valuation, stock price, and market status.
